Wlodarski K, Sawicki W, Kozyra A, Tajber L
Medical University of Gdansk, Department of Physical Chemistry, Hallera 107, 80-416 Gdansk, Poland.
Medical University of Gdansk, Department of Physical Chemistry, Hallera 107, 80-416 Gdansk, Poland.
Eur J Pharm Biopharm. 2015 Oct;96:237-46. doi: 10.1016/j.ejpb.2015.07.026. Epub 2015 Aug 4.
The aim of this paper was to evaluate physical stability of solid dispersions in respect to the drug, tadalafil (Td), in vinylpyrrolidone and vinyl acetate block copolymer (PVP-VA). Nine solid dispersions of Td in PVP-VA (Td/PVP-VA) varied in terms of quantitative composition (1:9-9:1, w/w) were successfully produced by spray-drying. Their amorphous nature, supersaturated character and molecular level of mixing (a solid solution structure) were subsequently confirmed using DSC, PXRD, SEM and calculation of Hansen total solubility parameters. Due to thermal degradation of both components before the melting point of Td (302.3°C), an approach based on the drug crystallization from the supersaturated solid dispersion was selected to calculate the solubility of Td in the polymer. Annealing of the Td/PVP-VA solid dispersion (1:1, w/w) at selected temperatures above its Tg resulted in different stable solid dispersions. According to the Gordon-Taylor equation their new Tgs gave the information about the quantitative composition which corresponded to the thermodynamic solubility of Td in PVP-VA at given temperatures of annealing. The obtained relationship was fitted to the exponential function, with the calculated solubility of Td of 20.5% at 25°C. This value was in accordance with the results of hot stage polarizing light microscopy as well as stability tests carried out at 80°C and 0% RH, in which Td solid dispersions containing 10-20% of the drug were the only systems that did not crystallize within two months. A thermal analysis protocol utilizing a fast heating rate was shown to generate Td solubility data complementing the solid dispersion method. The Flory-Huggins model applied for the Td/PVP-VA system yielded the solubility value of 0.1% at 25°C, showing the lack of applicability in this case.
本文旨在评估药物他达拉非(Td)在乙烯基吡咯烷酮和醋酸乙烯酯嵌段共聚物(PVP-VA)中的固体分散体的物理稳定性。通过喷雾干燥成功制备了九种不同定量组成(1:9 - 9:1,w/w)的Td在PVP-VA中的固体分散体(Td/PVP-VA)。随后使用差示扫描量热法(DSC)、粉末X射线衍射(PXRD)、扫描电子显微镜(SEM)以及汉森总溶解度参数计算,证实了它们的无定形性质、过饱和特性和分子水平的混合(固溶体结构)。由于在Td熔点(302.3°C)之前两种成分都会发生热降解,因此选择了一种基于过饱和固体分散体中药物结晶的方法来计算Td在聚合物中的溶解度。将Td/PVP-VA固体分散体(1:1,w/w)在高于其玻璃化转变温度(Tg)的选定温度下进行退火,得到了不同的稳定固体分散体。根据戈登 - 泰勒方程,它们新的Tg给出了关于定量组成的信息,该定量组成对应于给定退火温度下Td在PVP-VA中的热力学溶解度。将得到的关系拟合为指数函数,计算出25°C时Td的溶解度为20.5%。该值与热台偏光显微镜的结果以及在80°C和0%相对湿度下进行的稳定性测试结果一致,在这些测试中,含有10 - 20%药物的Td固体分散体是仅有的在两个月内未结晶的体系。结果表明,采用快速升温速率的热分析方法可生成补充固体分散体方法的Td溶解度数据。应用于Td/PVP-VA体系的弗洛里 - 哈金斯模型在25°C时得出的溶解度值为0.1%,表明在这种情况下该模型不适用。